OpenURL Connection Search

Select item for more details and to access through your institution.

TOX is expressed by exhausted and polyfunctional human effector memory CD8<sup>+</sup> T cells.
Published in:
Science Immunology, 2020, v. 5, n. 49, p. 1, doi. 10.1126/sciimmunol.aba7918
By:
- Sekine, Takuya;
- Perez-Potti, André;
- Nguyen, Son;
- Gorin, Jean-Baptiste;
- Wu, Vincent H.;
- Gostick, Emma;
- Llewellyn-Lacey, Sian;
- Hammer, Quirin;
- Falck-Jones, Sara;
- Vangeti, Sindhu;
- Yu, Meng;
- Smed-Sörensen, Anna;
- Gaballa, Ahmed;
- Uhlin, Michael;
- Sandberg, Johan K.;
- Brander, Christian;
- Nowak, Piotr;
- Goepfert, Paul A.;
- Price, David A.;
- Betts, Michael R.
Publication type:
Article
Elite control of HIV is associated with distinct functional and transcriptional signatures in lymphoid tissue CD8<sup>+</sup> T cells.
Published in:
Science Translational Medicine, 2019, v. 11, n. 523, p. 1, doi. 10.1126/scitranslmed.aax4077
By:
- Nguyen, Son;
- Deleage, Claire;
- Darko, Samuel;
- Ransier, Amy;
- Truong, Duc P.;
- Agarwal, Divyansh;
- Japp, Alberto Sada;
- Wu, Vincent H.;
- Kuri-Cervantes, Leticia;
- Abdel-Mohsen, Mohamed;
- Del Rio Estrada, Perla M.;
- Ablanedo-Terrazas, Yuria;
- Gostick, Emma;
- Hoxie, James A.;
- Zhang, Nancy R.;
- Naji, Ali;
- Reyes-Terán, Gustavo;
- Estes, Jacob D.;
- Price, David A.;
- Douek, Daniel C.
Publication type:
Article
Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants.
Published in:
2022
By:
- Smith, Robert A;
- Wu, Vincent H;
- Song, Jennifer;
- Raugi, Dana N;
- Mbaye, Khardiata Diallo;
- Seydi, Moussa;
- Gottlieb, Geoffrey S;
- Diallo Mbaye, Khardiata
Publication type:
journal article

Found: 3

TOX is expressed by exhausted and polyfunctional human effector memory CD8<sup>+</sup> T cells.

Elite control of HIV is associated with distinct functional and transcriptional signatures in lymphoid tissue CD8<sup>+</sup> T cells.

Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants.